EUVIMEDEUVIMED entdecken
Open Access

Use of curcumin and its nanopreparations in the treatment of inflammatory bowel disease

Zi-Wen Meng, Bing Chang, Li-Xuan Sang

World Journal of Gastroenterology · 21.01.2024 · 30 (3) · 280-282

DOI: 10.3748/wjg.v30.i3.280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Gastroenterology, online erschienen am 21.01.2024. Verfasst von Zi-Wen Meng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang 110022, Liaoning Province, China. Hauptthemen laut MEDLINE: Curcumin, Inflammatory Bowel Diseases, Colitis, Ulcerative, Crohn Disease. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is a nonspecific inflammatory disease of the intestine that includes Crohn’s disease and ulcerative colitis. Because IBD is difficult to heal and easily relapses, it could worsen patient quality of life and increase economic burdens. Curcumin (CUR) is a bioactive component derived from the rhizome of turmeric (Curcuma longa). Many basic and clinical studies have shown that CUR can efficiently treat IBD by decreasing the activity of proinflammatory cytokines by communicating with transcription factors and signaling molecules. However, due to the limitations of being almost insoluble in aqueous solutions and having low oral bioavailability, it is important to select appropriate pharmaceutical preparations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminInflammatory Bowel DiseasesColitis, UlcerativeCrohn DiseaseHumansQuality of Life

Stichwörter der Autor:innen

BioavailabilityCurcuminInflammatory bowel diseaseNanotherapeutics

Substanzen

Curcumin

Autor:innen und Institutionen

  • Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang 110022, Liaoning Province, China.
  • Department of Gastroenterology, the First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning Province, China.
  • Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang 110022, Liaoning Province, China. sanglixuan2008@163.com.

Zitieren

APA

Meng, Z. W., Chang, B., & Sang, L. X. (2024). Use of curcumin and its nanopreparations in the treatment of inflammatory bowel disease. World Journal of Gastroenterology, 30(3), 280-282. https://doi.org/10.3748/wjg.v30.i3.280

Vancouver

Meng ZW, Chang B, Sang LX. Use of curcumin and its nanopreparations in the treatment of inflammatory bowel disease. World Journal of Gastroenterology. 2024;30(3):280-282. doi:10.3748/wjg.v30.i3.280

BibTeX
@article{Meng2024,
  author = {Meng, Zi-Wen and Chang, Bing and Sang, Li-Xuan},
  title = {Use of curcumin and its nanopreparations in the treatment of inflammatory bowel disease},
  journal = {World Journal of Gastroenterology},
  year = {2024},
  volume = {30},
  number = {3},
  pages = {280--282},
  doi = {10.3748/wjg.v30.i3.280}
}
Kostenlos starten →